Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1328-1335. doi: 10.1002/pds.4853. Epub 2019 Jul 22.
The ability of the Clinical Practice Research Datalink (CPRD) to ascertain all-cause hospitalizations remains unknown. We determined the proportion of hospitalizations in CPRD that were also recorded in Hospital Episode Statistics (HES), and vice versa, among patients initiating oral antidiabetic (OAD) therapy.
We conducted a retrospective cohort study from October 2009 to September 2012 among OAD-treated patients registered with general practitioners who contribute to CPRD and consent to HES linkage. In CPRD, we identified initial hospitalizations for each calendar year by an Inpatient Referral, Consultation Type code, or Read code indicating an inpatient episode and determined if an admission date was recorded in HES within ±30 days. We then identified initial HES admission dates and determined if a hospitalization was documented in CPRD within ±30 days. Sensitivity analyses were conducted utilizing HES discharge, rather than admission, dates.
Among 8574 OAD-treated HES-linked patients in CPRD, 6574 initial hospitalizations across the study period were identified in CPRD, and 5188 (78.9% [95% CI, 77.9%-79.9%]) were confirmed by a HES admission date within ±30 days (median difference, ±3 days [IQR, 1-7 days]). Among 8609 initial hospital admissions in HES, 4803 (55.7% [95% CI, 54.7%-56.8%]) hospitalizations were recorded in CPRD within ±30 days (median difference, ±4 days [IQR, 1-9 days]). Similar results were observed using HES discharge dates.
A substantial minority of patient-level hospitalization data are nonconcordant between HES and CPRD. Pharmacoepidemiologic studies within CPRD that seek to identify hospitalizations should consider linkage with HES to ensure adequate ascertainment of inpatient events.
临床实践研究数据链(CPRD)确定全因住院的能力尚不清楚。我们确定了在接受口服抗糖尿病药物(OAD)治疗的患者中,CPRD 中记录的住院治疗与 HES 记录的住院治疗之间的比例,反之亦然。
我们对 2009 年 10 月至 2012 年 9 月期间在向 CPRD 提供数据且同意 HES 链接的全科医生注册的 OAD 治疗患者进行了回顾性队列研究。在 CPRD 中,我们通过住院转介、咨询类型代码或表明住院患者的 Read 代码来确定每个日历年度的首次住院治疗,并确定 HES 是否在±30 天内记录了入院日期。然后,我们确定了 HES 的首次入院日期,并确定在±30 天内是否在 CPRD 中记录了住院治疗。我们还利用 HES 的出院日期而不是入院日期进行了敏感性分析。
在 8574 名接受 OAD 治疗且与 HES 链接的 CPRD 患者中,研究期间在 CPRD 中确定了 6574 次初始住院治疗,其中 5188 次(78.9%[95%CI,77.9%-79.9%])通过 HES 入院日期±30 天内的记录得到确认(中位数差异,±3 天[IQR,1-7 天])。在 HES 中 8609 次初始住院中,4803 次(55.7%[95%CI,54.7%-56.8%])在 CPRD 中记录了±30 天内的住院治疗(中位数差异,±4 天[IQR,1-9 天])。使用 HES 的出院日期也得到了类似的结果。
HES 和 CPRD 之间的患者级别的住院数据有相当一部分不一致。在 CPRD 中进行的旨在识别住院治疗的药物流行病学研究应考虑与 HES 进行链接,以确保充分确定住院患者的事件。